scholarly article | Q13442814 |
P50 | author | Flore Kruiswijk | Q38546143 |
Shabaz Mohammed | Q41889840 | ||
Teck Yew Low | Q43146391 | ||
Ratna Lim | Q114454143 | ||
Michele Pagano | Q28357961 | ||
Daniele Guardavaccaro | Q28358019 | ||
Christopher G. Proud | Q30502222 | ||
P2093 | author name string | Albert J R Heck | |
Laurensia Yuniati | |||
Roberto Magliozzi | |||
Renske Bolder | |||
P2860 | cites work | Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 |
SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response | Q24298620 | ||
Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase | Q24306203 | ||
The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint | Q24317772 | ||
Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase | Q24319188 | ||
M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP | Q24329203 | ||
Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. | Q24535599 | ||
Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells | Q24548951 | ||
A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin | Q24599904 | ||
Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer | Q24648025 | ||
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels | Q27860531 | ||
The ubiquitin system | Q27860803 | ||
p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling | Q28117922 | ||
Function and regulation of cullin-RING ubiquitin ligases | Q28131707 | ||
Control of meiotic and mitotic progression by the F box protein beta-Trcp1 in vivo | Q28177348 | ||
Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage | Q28182301 | ||
SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase | Q28234989 | ||
Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398 | Q28237559 | ||
Regulation of peptide-chain elongation in mammalian cells | Q34992462 | ||
The mTOR pathway in the control of protein synthesis | Q36600753 | ||
Claspin: timing the cell cycle arrest when the genome is damaged | Q36685762 | ||
DNA damage checkpoints: from initiation to recovery or adaptation | Q36736655 | ||
Phosphopeptide fragmentation and analysis by mass spectrometry | Q37510777 | ||
Identification of calmodulin-dependent protein kinase III and its major Mr 100,000 substrate in mammalian tissues | Q37537893 | ||
Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis | Q39875666 | ||
Ribosomal slowdown mediates translational arrest during cellular division. | Q40100414 | ||
Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase | Q40427685 | ||
Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines | Q40622035 | ||
Control of the translational machinery in mammalian cells | Q40691293 | ||
p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation | Q40714283 | ||
Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway | Q41064925 | ||
Three phosphorylation sites in elongation factor 2. | Q41923582 | ||
Phosphorylation of elongation factor 2 in normal and malignant rat glial cells | Q42511654 | ||
A hierarchy of ATP-consuming processes in mammalian cells | Q42822664 | ||
Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes | Q48681530 | ||
Phosphorylation of the elongation factor 2: the fifth Ca2+/calmodulin-dependent system of protein phosphorylation | Q69041268 | ||
Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation. Phosphorylated EF-2 is unable to catalyze translocation | Q69665326 | ||
Identification of the phosphorylation sites in elongation factor-2 from rabbit reticulocytes | Q70162872 | ||
Purification and phosphorylation of elongation factor-2 kinase from rabbit reticulocytes | Q70587552 | ||
Evidence for control of protein synthesis in HeLa cells via the elongation rate | Q71332333 | ||
Analysis of the domain structure of elongation factor-2 kinase by mutagenesis | Q78203491 | ||
Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress | Q28255529 | ||
Elongation factor-2 kinase: its role in protein synthesis and autophagy | Q28259016 | ||
Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery | Q28260190 | ||
The DNA damage response: ten years after | Q28261230 | ||
Regulation of elongation factor-2 by multisite phosphorylation | Q28263254 | ||
S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth | Q28269583 | ||
Purification and characterization of calmodulin-dependent protein kinase III from rabbit reticulocytes and rat pancreas | Q28270230 | ||
Control of chromosome stability by the beta-TrCP-REST-Mad2 axis | Q28273354 | ||
The SCF ubiquitin ligase: insights into a molecular machine | Q28279993 | ||
Cell-cycle checkpoints and cancer | Q28293996 | ||
Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation | Q28297499 | ||
Functional properties of phosphorylated elongation factor 2 | Q28572074 | ||
Cloning and expression of cDNA encoding protein synthesis elongation factor-2 kinase | Q28576070 | ||
Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis | Q28585415 | ||
Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD | Q28585633 | ||
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification | Q29547200 | ||
Growing roles for the mTOR pathway | Q29616212 | ||
mTOR and cancer: many loops in one pathway. | Q33348248 | ||
Specific phosphopeptide enrichment with immobilized titanium ion affinity chromatography adsorbent for phosphoproteome analysis | Q33352234 | ||
Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes. | Q33447106 | ||
Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases | Q33756957 | ||
The coordinate regulation of the p53 and mTOR pathways in cells | Q33840457 | ||
Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways | Q33920035 | ||
In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation | Q34286428 | ||
Elongation factor-2 phosphorylation and the regulation of protein synthesis by calcium | Q34383415 | ||
Regulation of mammalian translation factors by nutrients | Q34992453 | ||
P433 | issue | 227 | |
P921 | main subject | genotoxicity | Q1009245 |
P304 | page(s) | ra40 | |
P577 | publication date | 2012-06-05 | |
P1433 | published in | Science Signaling | Q7433604 |
P1476 | title | Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress | |
P478 | volume | 5 |
Q38758189 | A Systems Survey of Progressive Host-Cell Reorganization during Rotavirus Infection |
Q40603479 | A conserved loop in the catalytic domain of eukaryotic elongation factor 2 kinase plays a key role in its substrate specificity |
Q57666020 | A systems-wide screen identifies substrates of the SCF TrCP ubiquitin ligase |
Q41005662 | At the Interface of Three Nucleic Acids: The Role of RNA-Binding Proteins and Poly(ADP-ribose) in DNA Repair |
Q36274938 | Bouvardin is a Radiation Modulator with a Novel Mechanism of Action |
Q42378457 | Calyxin Y sensitizes cisplatin-sensitive and resistant hepatocellular carcinoma cells to cisplatin through apoptotic and autophagic cell death via SCF βTrCP-mediated eEF2K degradation |
Q39210209 | Comparative proteomic analysis implicates eEF2 as a novel target of PI3Kγ in the MDA-MB-231 metastatic breast cancer cell line |
Q35668793 | DNA Damage Regulates Translation through β-TRCP Targeting of CReP |
Q38407259 | Datasets from an interaction proteomics screen for substrates of the SCF(βTrCP) ubiquitin ligase |
Q42547521 | Degradation of Tiam1 by casein kinase 1 and the SCFβTrCP ubiquitin ligase controls the duration of mTOR-S6K signaling |
Q39854446 | Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia |
Q26775071 | Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases |
Q36418560 | Exploring G protein-coupled receptor signaling networks using SILAC-based phosphoproteomics |
Q54506429 | F-box proteins elongate translation during stress recovery. |
Q37063923 | IRS1 deficiency protects β-cells against ER stress-induced apoptosis by modulating sXBP-1 stability and protein translation. |
Q48194481 | Intrauterine growth restriction inhibits expression of eukaryotic elongation factor 2 kinase, a regulator of protein translation. |
Q28266122 | Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor |
Q38899171 | Molecular Mechanism for the Control of Eukaryotic Elongation Factor 2 Kinase by pH: Role in Cancer Cell Survival |
Q35113557 | Molecular mechanisms of 3,3'-dichlorobenzidine-mediated toxicity in HepG2 cells |
Q41049605 | Paradoxical Roles of Elongation Factor-2 Kinase in Stem Cell Survival |
Q39322193 | Phosphorylation of elongation factor-2 kinase differentially regulates the enzyme's stability under stress conditions |
Q36929118 | Proteasomal degradation of eukaryotic elongation factor-2 kinase (EF2K) is regulated by cAMP-PKA signaling and the SCFβTRCP ubiquitin E3 ligase |
Q38268314 | Proteasome-dependent degradation of transcription factor activating enhancer-binding protein 4 (TFAP4) controls mitotic division |
Q97590561 | SCFSKP2 regulates APC/CCDH1-mediated degradation of CTIP to adjust DNA-end resection in G2-phase |
Q38726534 | Signal Integration at Elongation Factor 2 Kinase: THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION. |
Q30660043 | The CRAPome: a contaminant repository for affinity purification-mass spectrometry data |
Q35934147 | The Role of Translational Regulation in Survival after Radiation Damage; an Opportunity for Proteomics Analysis. |
Q58095165 | The Yeast DNA Damage Checkpoint Kinase Rad53 Targets the Exoribonuclease, Xrn1 |
Q28243673 | The molecular mechanism of eukaryotic elongation factor 2 kinase activation |
Q33636990 | The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers. |
Q38087182 | The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer |
Q37710220 | Translational reprogramming in cellular stress response |
Q34592732 | USP17- and SCFβTrCP--regulated degradation of DEC1 controls the DNA damage response |
Q46609299 | Ubiquitin ligases in oncogenic transformation and cancer therapy |
Q38047273 | Unraveling the ubiquitin-regulated signaling networks by mass spectrometry-based proteomics. |
Q40608421 | Using docking and alchemical free energy approach to determine the binding mechanism of eEF2K inhibitors and prioritizing the compound synthesis |
Q38833602 | VprBP/DCAF1 Regulates the Degradation and Nonproteolytic Activation of the Cell Cycle Transcription Factor FoxM1. |
Q90103143 | What Drosophila Can Teach Us About Radiation Biology of Human Cancers |
Q57039572 | mTORC1/2 and protein translation regulate levels of CHK1 and the sensitivity to CHK1 inhibitors in Ewing sarcoma cells |
Search more.